Pascal Medical
Richmond, US · Founded 2022 · Delaware corporation
Pascal Life Sciences is a medtech company developing injectable hydrogel therapeutics using click chemistry. Its ClickGel platform is a biocompatible, biodegradable gel for local delivery of biologics, antibiotics, and tissue sealants.
BiotechHealthtechMedical Devices
Founders & leadership
BD
Barbara Dale BoyanExecutive Officer, Director, Promoter
RH
Richard HallExecutive Officer, Director, Promoter
TW
Thomas William GardnerExecutive Officer, Director
RW
Richard William HallExecutive Officer, Director
JC
James Craig SeveyExecutive Officer
BB
Barbara BoyanCo-Founder
WG
William Gregory SmartDirector
DQ
Donald Quartel Jr.Director
Reported raises · per SEC filings
Form D private placements▶$3.1MraisedJul 2026 · 39 investors · OtherRule 506(b)
▶$3.1MraisedJul 2026 · 39 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Thomas William GardnerExecutive Officer, Director
- Barbara Dale BoyanExecutive Officer, Director
- Richard William HallExecutive Officer, Director
- William Gregory SmartExecutive Officer, Director
- James Craig SeveyExecutive Officer
- Offering amount
- $3.1M
- Amount sold
- $3.1M
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$2.6MraisedJun 2025 · 32 investors · OtherRule 506(b)
▶$2.6MraisedJun 2025 · 32 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Barbara Dale BoyanExecutive Officer, Director, Promoter
- William Gregory SmartDirector
- Richard HallExecutive Officer, Director, Promoter
- Donald Quartel Jr.Director
- Offering amount
- $2.6M
- Amount sold
- $2.6M
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| U.S. Air ForceAir Force | Phase ISTTR | 2023 | $74.8K |
| U.S. Air ForceAir Force | Phase ISTTR | 2023 | $74.8K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.